Perinatal Biologics Supplier Serving Orthopedic Clinics in Bridgeport, CT

Vendor qualification for orthopedic accounts

Orthopedic practices and ambulatory surgery centers typically route a new tissue or biologics vendor through a vendor qualification process before any product reaches a shelf. That review usually involves a practice administrator or surgery center compliance lead, working alongside the medical director, to confirm the distributor can produce documentation on request.

Precision Biologics supports this review by making a certificate of analysis, a donor eligibility summary, and a lot release record available to verified accounts for each lot. We do not publish specifications or test results publicly; qualified buyers request the documentation that matches their internal review checklist.

NPI verification and account setup

Every Precision Biologics account begins with NPI verification. We check the number against the NPPES registry and confirm the applicant is a licensed professional or an entity ordering under one, consistent with how orthopedic practices already manage controlled vendor relationships.

Once an account is verified, pricing and ordering become available; pricing is never published publicly. A single point of contact at the practice can manage reorders and documentation requests across multiple product lines.

• NPI number
• Practice or facility name and license information
• A designated ordering contact

Receiving cryopreserved shipments in the Northeast

Cryopreserved Wharton's jelly and exosome products ship overnight on dry ice in validated containers maintained near -80 degrees C from recovery through delivery. Practices in the Northeast region, including Bridgeport, receive shipments through standard overnight carrier networks rather than a regional distribution model.

We recommend that receiving staff log the lot identifier against the packing list immediately on arrival and store product according to the accompanying handling instructions, since traceability at the clinic level depends on that lot record.

Medical director and regulatory verification

Whether a specific intended use for a Wharton's jelly or exosome product fits within a practice's existing regulatory framework is a determination for the practice's medical director and legal counsel, not for Precision Biologics. We recommend verifying any clinical use decision with the Connecticut medical board and independent counsel before adopting a product into a procedure.

Precision Biologics makes physician-level documentation conversations available to verified accounts. These calls address product sourcing, processing description, and testing documentation; they are not clinical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.